37
Views
38
CrossRef citations to date
0
Altmetric
Review papers

The Discovery of the Pathophysiological Aspects of Atherosclerosis — A Review

, &
Pages 162-169 | Published online: 16 Nov 2020

References

  • Ruffer M. A. On arterial lesions found in Hgyptia mummies. J Path Bad, 1911, 15 : 453-465.
  • Graul E. H. Environtologie - Fakten und Spekulationen. Medicef, 1985, 1 : 1-24.
  • Kohn H. Zur Geschichte der Angina pectoris. Zschr klin Med, 1927, 106.
  • Vesal A. De humani corporis fabrica. 1543, Basel.
  • Fallopius G. Lectiones de partibus simularibus humani corporis. 1575, Padua.
  • Harvey W. Exercitatio anatomica de motu cordis et sanguinis animalibus, 1628, London.
  • Morgagni G. B. De sedibus et causis morborum. 1761, Venice.
  • Von Haller A. Bibliotheca anatomica, Vol. II, 1774, Zurich.
  • Heberden W. Some account to a disorder of the breast. Medical Transactions, Vol. II, London Read at the College, July 21st 1768.
  • Jenner E. Letter on the relationship of coronary artery disease to angina pectoris. 1799 (cited in Kohn 1927).
  • Parry C. H. In inquiry into the symptoms and causes of the syncope anginosa, commonly called angina pectoris. London 1799 (cited in Kohn 1927).
  • Potain A. Des differentes formes de l’angine de poitrine. Gaz de’Hop 1880, p. 96 (cited in Kohn 1927).
  • Lobstein J. F. Lehrbuch der pathologischen Anatomie. Vol. II, 1835, Brodhag’sche Buchhandlung Stuttgart.
  • Rokitansky C. Über einige der wichtigsten Krankheiten der Arterien. 1852, K.u.K. hof- und Staatsdruckereinen, Wien.
  • Virchow R. Über parenchymatöse Entzündung. Virclwws Arehiv PathAnat, 1852,4: 261-276.
  • Saltykow S. Atherosklerose bei Kaninchen nach wiederholter Staphylokokkeninjektion. In : Aschoff L, Marchand F. (eds.) Beitrage Pathologische Anatomie. 43rd Edition, Jena, Fischer 1908, p. 147-176.
  • STUCKEY. Über die Veränderungen der Kaninchenaorta unter dem Einflusse einer reichlichen animalischen Futterung. Inaugural-Dissertation, St. Petersburg, 1910.
  • Anitschkow N. Über die Veränderungen der Kaninchenaorta bei experimenteller Cholesterinsteatose. Beilr Pathol Anat, 1913, 56 : 379-404.
  • Finking G., Hanke H. Nikolaj Nikolalajewitsch Anitschkow (1885-1964) established the cholesterol-fed rabbit as a model for atherosclerosis research. Atherosclerosis 1997, 135 : 1-7.
  • Ludden J. B., Bruger M, Wright I. S. Experimental atherosclerosis. IV. Effect of testosterone propionate and estradiol dipropionate on experimental atherosclerosis in rabbits. Arch Path, 1942, 33 : 58-62.
  • Ross R., Glomset J. A. The pathogenesis of atherosclerosis (part I). NEJM, 1976, 295 : 369-377.
  • Ross R., Glomset J. A. The pathogenesis of atherosclerosis (part 1). NEJM, 1976, 295 : 420-425.
  • Bostom A. G., Selhub J. Homocysteine and arteriosclerosis. Circulation, 1999, 99 : 2361-2363.
  • Gupta S. Chronic infection in the aetiology of atherosclerosis - focus on Chlamydia pneumoniae. Atherosclerosis, 1999, 143 : 1-6.
  • Koenig W., Sund M., Frohlich M., Fischer H. G., Lowel H, Doring A., Hutchinson W. L., Pepys M. B. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men : results from the MONICA (Monitoring Trends ans Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992). Circulation, 1999, 99 : 237-242.
  • Brown M. S., Goldstein J. L. A receptor-mediated pathway for cholesterol homeostasis. Science, 1986, 232 : 34-47.
  • Ross R. The pathogenesis of atherosclerosis : a perspective for the 1990s. Nature, 1993, 362 : 801-809.
  • Stary H. C. Composition and classification of human atheroscle-rosic lesions. Virchows Arch A Pathol Anat, 1992, 421 : 277-290.
  • Fuster V., Badimon L., Badimon J. J., Cheesebro J. H. The pathogenesis of coronary artery disease and the acute coronary syndromes. NEJM, 1992, 326 : 242-250.
  • Giroud D, Li J. M., Urban P, Meier B, Rutishauser W. Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am J Cardiol, 1992, 69 : 729-732.
  • Hanke H., HÖHer M. Stellenwert der Cholesterinsenkung in der Sekundärprävention der koronaren Herzerkrankung. Med Welt, 1999, 50 : 153-159.
  • Golledge J., Greenhalgh R. M., Davies A. H. The symptomatic carotid plaque. Stroke, 2000, 31: 774-781.
  • Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet, 1994, 344 : 1383-1389.
  • Shepard J., Cobbe S. M., Ford I., Isles C. G., Lorimer A. R., Macfarlane P. W., Mckillop J. H., Packard C. J. for the West of Scotland Coronary Prevention Study Group : Prevention of coronary heart diseasewith pravastatin in men with hypercholesterolemia. N Eng J Med, 1995, 333 : 1301-1307.
  • Sacks F. M., Pfeffer M. A., Move L. A., Rouleau J. L., Rutherford J. D., Cole T. G., Brown L., Warnica J. W., Arnold J. M. O., Wun C. C., Davies B. R., Braunwald E. for the Cholesterol and Recurrent Events Trial Investigators : The effect of pravastatin in coronary events after myocardial infarction in patients with average cholesterol levels. N Eng J Med, 1996,335 : 1001-1009.
  • Lipid Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med, 1998, 339 : 1349-1357.
  • Stamler J., Wentworth D., Neaton J. D. for the MRFIT Research Group : Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous or graded? Findings in 356 222 primary screenes of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA, 1986, 256 : 2823-2838.
  • Ornish D., Brown S. E., Scherwitz L. W., Billings J. H., Armstrong W. T., Ports T. A., Mclanahan S. M., Kirkeide R. L., Brand R. J., Gould K. L. Can lifestyle changes reverse coronary heart disease? Lancet, 1990, 336 : 129-133.
  • Brown B. G., Zhao X.-Q., Sacco D. E., Albers J. J. Lipid lowering and plaque regression - new insights into prevention of plaque disruption and clinical events in coronary disease. Circulation, 1993, 87 : 1781-1791.
  • Deutsche Gesellschaft fur Kardiologie : Leitlinie: Koronare Herzkrankheit/Angina pectoris. Z Kardiol, 1998, 87 : 907-911.
  • Wood D., De Backer G., Faergrman O., Graham I., Mancia G., PyÖrÄlÄ K. together with members of the Task Fores : Prevention of coronary heart disease in clinical practice. Eur Heart J, 1994, 15: 1300-1331.
  • Ross R. The pathogenesis of atherosclerosis : An update. N Eng J Med, 1986, 314 : 488-500.
  • Ross R. Atherosclerosis - an inflammatory disease. N Eng J Med, 1999, 340: 115-126.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.